Owlet Component Library — Part 2

AdaptHealth and their Sales Team are working to support you getting access to BabySat®. Follow the link here and pre-register to receive pertinent marketing collateral, and order forms/RX pads.

BabySat® is FDA-cleared and clinically-proven to be safe and accurate for monitoring your infant's vitals at home. BabySat® requires a prescription from a healthcare provider, and may or may not be eligible for partial or full reimbursement through your health insurance plan. To find out if your insurance is accepted place an order via the online order form.

Yes! Owlet announced FDA Clearance of Dream Sock. Dream Sock is the first and only non-prescription baby monitor with FDA-cleared Live Health Readings and Health Notifications for healthy babies between 1 to 18 months. Available to current and new Dream Sock users.

BabySat® is not the same product as Smart Sock, as BabySat® is a new FDA-cleared medical device to be prescribed by healthcare providers in the US and Smart Sock is a consumer product offered only outside of the US and Canada. BabySat® provides real-time alerts if pulse rate or oxygen saturation level falls outside a prescribed zone. Unlike Smart Sock, BabySat® has adjusted reading levels and is a prescription only device that should be used in partnership with your healthcare provider.

Owlet does not anticipate marketing Smart Sock within the US or Canada in the future. Dream Sock is the first and only non-prescription baby monitor with FDA-cleared Live Health Readings and Health Notifications for healthy babies between 1 to 18 months. Available to current and new Dream Sock users.

BabySat® has a rechargeable, battery-powered sensor which is secured over an infant’s foot with a fabric sock. The sensor is capable of detecting pulse rate, SpO2, and motion levels. BabySat® has customizable alarm limits for pulse rate and SpO2 which can be set to alert for critical values according to your patient’s needs. Graphs of historical vital sign data are also viewable through the Care+ App to reveal clinical trends which can help inform clinical decisions and effectively engage home caregivers in the infant’s plan of care.

BabySat® has undergone a series of rigorous accuracy testing in adult and infant study subjects. These studies were required for FDA clearance and reviewed by experts to ensure that our device meets standards set by the International Organization for Standardization. BabySat® accuracy for pulse rate and SpO2 are found in the user manual, as well as the Fact Sheet.

Here is a helpful link to showcase what is required on a prescription.